CELC — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

22.94

Margin Of Safety %

Put/Call OI Ratio

0.45

EPS Next Q Diff

-0.12

EPS Last/This Y

0.26

EPS This/Next Y

4.27

Price

138.21

Target Price

169

Analyst Recom

Performance Q

31.46

Upside

-198.7%

Beta

0.11

Ticker: CELC

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-04-23	CELC	113.48	0.31	0.34	25406
2026-04-24	CELC	121.08	0.31	0.07	25582
2026-04-27	CELC	125.72	0.32	0.45	25490
2026-04-28	CELC	120.07	0.29	0.39	27556
2026-04-29	CELC	118.35	0.29	0.44	27620
2026-04-30	CELC	121.23	0.30	0.18	27692
2026-05-01	CELC	125.78	0.30	0.37	27712
2026-05-04	CELC	145.14	0.31	2.41	31109
2026-05-05	CELC	141.72	0.35	0.14	33418
2026-05-06	CELC	139.32	0.35	0.09	34764
2026-05-07	CELC	130.94	0.37	0.64	34396
2026-05-08	CELC	131.08	0.55	0.23	37792
2026-05-11	CELC	125.42	0.55	0.07	38060
2026-05-12	CELC	124.62	0.52	0.44	39521
2026-05-13	CELC	124.55	0.52	0.04	39462
2026-05-14	CELC	135.14	0.48	0.77	41753
2026-05-15	CELC	137.9	0.48	3.35	43530
2026-05-18	CELC	132.16	0.46	1.17	31659
2026-05-19	CELC	131.16	0.45	0.51	32948
2026-05-20	CELC	140.13	0.45	0.98	34091
2026-05-21	CELC	142.48	0.47	0.88	35002
2026-05-22	CELC	138.12	0.45	0.01	35027
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-04-23	CELC	113.47	-25.3	-	-3.78
2026-04-24	CELC	121.10	-25.3	-	-3.78
2026-04-27	CELC	125.75	-25.3	-	-3.78
2026-04-28	CELC	120.04	-25.3	-	-3.78
2026-04-29	CELC	119.08	-25.3	-	-3.78
2026-04-30	CELC	121.34	-25.3	-	-3.78
2026-05-01	CELC	125.85	-25.3	-	-3.78
2026-05-04	CELC	145.01	-25.3	-	-3.78
2026-05-05	CELC	141.62	-25.3	-	-3.78
2026-05-06	CELC	139.40	-25.3	-	-3.78
2026-05-07	CELC	130.79	-9.9	-	-3.93
2026-05-08	CELC	131.05	-9.9	-	-3.93
2026-05-11	CELC	125.64	-9.9	-	-3.93
2026-05-12	CELC	124.69	-9.9	-	-3.93
2026-05-13	CELC	124.47	-9.9	-	-3.93
2026-05-14	CELC	134.79	-9.9	-	-3.93
2026-05-15	CELC	137.77	-9.9	-	-3.93
2026-05-18	CELC	132.34	-9.9	-	-3.93
2026-05-19	CELC	131.00	-9.9	-	-3.93
2026-05-20	CELC	140.39	-5.4	-	-3.53
2026-05-21	CELC	142.48	-5.4	-	-3.53
2026-05-22	CELC	138.21	-5.4	-	-3.53
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-04-23	CELC	-0.44	7.64	22.87
2026-04-24	CELC	-0.46	7.64	22.87
2026-04-27	CELC	-0.46	7.36	22.88
2026-04-28	CELC	-0.46	7.36	22.88
2026-04-29	CELC	-0.46	7.36	22.88
2026-04-30	CELC	-0.46	7.36	22.88
2026-05-01	CELC	-0.46	7.36	22.88
2026-05-04	CELC	-0.46	6.49	22.88
2026-05-05	CELC	-0.46	6.49	22.88
2026-05-06	CELC	-0.46	6.49	22.88
2026-05-07	CELC	-0.80	6.49	22.88
2026-05-08	CELC	-0.80	6.49	22.88
2026-05-11	CELC	-0.80	4.90	22.88
2026-05-12	CELC	-0.80	4.90	23.19
2026-05-13	CELC	-0.81	4.90	23.19
2026-05-14	CELC	-0.81	4.90	23.19
2026-05-15	CELC	-0.81	4.90	23.19
2026-05-18	CELC	-0.80	4.80	22.95
2026-05-19	CELC	-0.80	4.80	22.97
2026-05-20	CELC	-0.80	4.80	22.97
2026-05-21	CELC	-0.80	4.80	22.94
2026-05-22	CELC	-0.77	4.80	22.94
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

-0.97

Avg. EPS Est. Current Quarter

-0.98

Avg. EPS Est. Next Quarter

-1.08

Insider Transactions

-0.77

Institutional Transactions

4.8

Beta

0.11

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

8.5

Max Drawdown 5-Year %

-82.7

Target Price

169

P/E

Forward P/E

PEG

P/S

P/B

124.86

P/Free Cash Flow

EPS

-3.9

Average EPS Est. Cur. Y

-3.53

EPS Next Y. (Est.)

0.74

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.75

Return on Equity vs Sector %

-387.4

Return on Equity vs Industry %

-371.8

EPS 1 7Days Diff

0.4

EPS 1 30Days Diff

0.25

EBIT Estimation

◆ CELC Healthcare

$138.23

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

0/20

Pullback

10/25

Volume

9/15

Valuation

6/20

TP/AR

6/10

Options

8/10

RSI

57.5

Range 1M

75.1%

Sup Dist

0.4%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

6/25

Growth

12/30

Estimates

5/20

Inst/Vol

8/15

Options

7/10

EPS Yr

-5.4%

EPS NY

92.5%

52W%

92.1%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🔴 SELL -51.7% upside

Quality

2/30

Valuation

0/30

Growth

11/25

Stability

5/10

LT Trend

1/5

Upside

-51.7%

Quality

Celcuity Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 155

Celcuity Inc., a clinical-stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's lead drug candidate includes Gedatolisib, which selectively targets various Class I isoforms of phosphatidylinositol-3-kinase (PI3K) and the two mechanistic targets of rapamycin (mTOR) sub-complexes, mTORC1 and mTORC2 to treat patients with hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2-) or HR+/HER2-, advanced or metastatic breast cancer (ABC), and patients with metastatic castration resistant prostate cancer (mCRPC). The company had a license agreement with Pfizer Inc. for the development and commercialization rights to Gedatolisib. Celcuity Inc. was incorporated in 2011 and is based in Minneapolis, Minnesota.

CELC

Latest News

—

Caricamento notizie per CELC…

stock quote shares CELC – Celcuity Inc. Stock Price stock today

news today CELC – Celcuity Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch CELC – Celcuity Inc. yahoo finance google finance

stock history CELC – Celcuity Inc. invest stock market

stock prices CELC premarket after hours

ticker CELC fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: CELC

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y